Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

SIMPLE SUMMARY: After the recent irruption of asciminib into the therapeutic arsenal for chronic myeloid leukemia, real-life data remain scarce to determine which patients may benefit most from this drug. Data on the efficacy of the drug in real-world setting have been reported, but a detailed analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Lamas, Lucía, Luna, Alejandro, Boque, Concepción, Xicoy, Blanca, Giraldo, Pilar, Pérez López, Raúl, Ruiz Nuño, Concepción, De las Heras, Natalia, Mora Casterá, Elvira, López Marín, Javier, Segura Díaz, Adrián, Gómez, Valle, Vélez Tenza, Patricia, Sierra Pacho, Magdalena, Vera Goñi, Juan Antonio, Moreno Vega, Melania, Alvarez-Larrán, Alberto, Cortés, Montse, Pérez Encinas, Manuel, Carrascosa Mastell, Patricia, Angona, Anna, Rosell, Ana, Lakhwani, Sunil, Colorado, Mercedes, Ramila, Elena, Cervero, Carlos, Cuevas, Beatriz, Villalón Blanco, Lucía, de Paz, Raquel, Paz Coll, Antonio, Fernández, María José, Felipe Casado, Luis, Alonso-Domínguez, Juan Manuel, Anguita Arance, María Magdalena, Salamanca Cuenca, Araceli, Jiménez-Velasco, Antonio, Prendes, Santiago Osorio, Santaliestra, Marta, Lis Chulvi, María José, Hernández-Boluda, Juan Carlos, García-Gutiérrez, Valentín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954054/
https://www.ncbi.nlm.nih.gov/pubmed/36831388
http://dx.doi.org/10.3390/cancers15041045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954054/
https://www.ncbi.nlm.nih.gov/pubmed/36831388
http://dx.doi.org/10.3390/cancers15041045

Ejemplares similares